ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
유전자 침묵 시장 규모는 향후 몇 년 동안 빠르게 성장할 것으로 예상되며, 2029년까지 연평균 성장률(CAGR) 12.9%로 109억 5,000만 달러에 달할 것으로 예상됩니다. 예측 기간의 성장은 희귀 질환에 대한 적용 확대, 전달 시스템의 기술 발전, 맞춤형 의료에 대한 수요 증가, 정부 지원 이니셔티브, 제약사와 바이오테크 기업의 파트너십 확대에 기인합니다. 이 기간 동안 예상되는 주요 동향으로는 표적 유전자 치료제 개발, CRISPR 기반 침묵화 접근법의 부상, 희귀질환 및 희귀질환에 대한 관심 증가, 나노입자 전달 기술의 등장, 유전자 침묵화 애플리케이션의 농업 분야로의 확대 등이 있습니다.
유전성 질환의 유병률 증가는 향후 몇 년 동안 유전자 침묵 시장의 성장을 크게 촉진할 것으로 예상되며, DNA 이상으로 인한 건강 상태인 유전 질환은 진단 기술의 발전, 인식의 향상, 유전자 검사에 대한 광범위한 접근성으로 인해 점점 더 많이 발견되고 있습니다. 발견되고 있습니다. 유전성 질환의 발병률 증가의 주요 요인 중 하나는 부모의 연령이 증가함에 따라 유전자 돌연변이가 자녀에게 유전될 가능성이 높아졌다는 점입니다. 유전자 침묵은 유해한 유전자나 질병을 유발하는 유전자의 발현을 선택적으로 억제함으로써 유전성 질환에 대처할 수 있는 유망한 해결책을 제시하고 있습니다. 예를 들어, 영국에 기반을 둔 자선단체인 Down Syndrome UK에 따르면, 다운증은 영국에서 약 4만 명이 앓고 있으며, 약 800명당 1명의 비율로 다운증후군 아기가 태어나고 있습니다. 이러한 유전성 질환의 유병률 증가가 유전자 침묵 시장에 박차를 가하고 있습니다.
유전자 침묵 시장의 주요 기업들은 유전자 치료의 정확성과 효능을 향상시키기 위해 작은 간섭 RNA(siRNA)와 같은 혁신적인 기술 개발에 집중하고 있습니다. 소분자 간섭 RNA(siRNA)는 특정 메신저 RNA(mRNA)에 결합하여 그 분해를 촉진하여 질병을 유발하는 단백질의 생성을 막는 RNA 간섭(RNAi) 경로에서 중요한 역할을 하는 RNA 분자입니다. 예를 들어, 2024년 10월 미국 생명공학 기업 Judo Bio Inc.는 유전자를 침묵시키도록 설계된 차세대 siRNA 약물을 출시하였습니다. 이 약물전달체에는 지질 나노입자 및 결합 리간드와 같은 독자적인 전달 시스템이 내장되어 있어 특정 세포와 조직에 효율적으로 흡수될 수 있으며, 잠재적인 유전자 표적의 식별을 가속화하는 AI 기반 플랫폼이 탑재되어 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 유전자 침묵 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업 분석
세계의 유전자 침묵 시장 : 성장률 분석
세계의 유전자 침묵 시장 실적 : 규모와 성장, 2019-2024년
세계의 유전자 침묵 시장 예측 : 규모와 성장, 2024-2029년, 2034년
세계의 유전자 침묵 전체 시장(TAM)
제6장 시장 세분화
세계의 유전자 침묵 시장 : 유형별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
전사
전사 후
감수분열
세계의 유전자 침묵 시장 : 유전자 침묵별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
RNA 간섭(RNAi)
안티센스 올리고뉴클레오티드(ASO)
CRISPR 또는 Cas9 기반 유전자 침묵
기타 유전자 침묵
세계의 유전자 침묵 시장 : 용도별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
신경학
종양학
감염증
대사성 질환
치료제 제조
기타 용도
세계의 유전자 침묵 시장 : 최종사용자별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
제약 및 바이오테크놀러지 기업
연구기관 및 학술 센터
병원
클리닉
기타 최종사용자
세계의 유전자 침묵 시장, 전사 하위 세분화, 유형별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
DNA 메틸화
히스톤 변형
세계의 유전자 침묵 시장, 전사 후 하위 세분화, 유형별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
RNA 간섭(RNAi)
안티센스 올리고뉴클레오티드
마이크로 RNA(miRNA)에 의한 침묵
세계의 유전자 침묵 시장, 감수분열 하위 세분화, 유형별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
감수분열 유전자 변환
전이 인자 침묵
제7장 지역별·국가별 분석
세계의 유전자 침묵 시장 : 지역별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
세계의 유전자 침묵 시장 : 국가별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
유전자 침묵 시장 : 경쟁 구도
유전자 침묵 시장 : 기업 개요
Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis
Novartis International AG Overview, Products and Services, Strategy and Financial Analysis
Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 주요 기업과 혁신적 기업
Danaher Corporation
Agilent Technologies Inc.
Illumina Inc.
Bio-Rad Laboratories Inc.
Bio-Techne Corporation
Alnylam Pharmaceuticals Inc.
GenScript Biotech Corporation
Oxford BioMedica plc
Ionis Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc.
Dicerna Pharmaceuticals Inc.
New England Biolabs Inc.
Quark Pharmaceuticals Inc.
Sirion Biotech GmbH
Benitec Biopharma Limited
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병
제34장 최근의 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
유전자 침묵 시장 2029년 : 새로운 기회를 제공하는 국가
유전자 침묵 시장 2029년 : 새로운 기회를 제공하는 부문
유전자 침묵 시장 2029년 : 성장 전략
시장 동향에 기반한 전략
경쟁 전략
제36장 부록
ksm
영문 목차
영문목차
Gene silencing is a biological process in which the expression of a specific gene is reduced or completely turned off. This process plays a crucial role in regulating gene activity, controlling development, and defending against viral infections. Gene silencing is essential in both research and medicine, particularly for targeting disease-related genes.
The main types of gene silencing include transcriptional, post-transcriptional, and meiotic. Transcriptional silencing refers to the regulation of gene expression at the transcription stage, where RNA is synthesized from a DNA template. Key gene silencing techniques include RNA interference (RNAi), antisense oligonucleotides (ASOs), and CRISPR/Cas9-based gene silencing, among others. These methods are applied across various fields such as neurology, oncology, infectious diseases, metabolic diseases, and therapeutic manufacturing. The primary end-users of gene silencing technologies include pharmaceutical and biotechnology companies, research institutes and academic centers, hospitals, clinics, and other related organizations.
The gene silencing market research report is one of a series of new reports from The Business Research Company that provides gene silencing market statistics, including the gene silencing industry global market size, regional shares, competitors with the gene silencing market share, detailed gene silencing market segments, market trends, and opportunities, and any further data you may need to thrive in the gene silencing industry. These gene silencing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The gene silencing market size has grown rapidly in recent years. It will grow from $5.97 billion in 2024 to $6.75 billion in 2025 at a compound annual growth rate (CAGR) of 13.0%. The growth during the historic period can be attributed to the growing research in genetic therapies, early breakthroughs in RNA interference, the increasing prevalence of genetic disorders, rising investment in biotechnology, and the expanding biopharmaceutical manufacturing capabilities.
The gene silencing market size is expected to see rapid growth in the next few years. It will grow to $10.95 billion in 2029 at a compound annual growth rate (CAGR) of 12.9%. The growth in the forecast period can be attributed to the expanding applications in rare diseases, technological advancements in delivery systems, increasing demand for personalized medicine, supportive government initiatives, and growing partnerships between pharmaceutical and biotechnology companies. Major trends expected during this period include the development of targeted gene therapies, the rise of CRISPR-based silencing approaches, a greater focus on rare and orphan diseases, the emergence of nanoparticle delivery technologies, and the expansion of gene silencing applications into agriculture.
The growing prevalence of genetic disorders is expected to significantly drive the expansion of the gene silencing market in the coming years. Genetic disorders, which are health conditions caused by DNA abnormalities, are being increasingly detected due to advancements in diagnostic technologies, improved awareness, and wider access to genetic testing. One of the main contributors to the rising incidence of genetic disorders is the increasing age of parents, which raises the likelihood of genetic mutations being passed to their children. Gene silencing presents a promising solution for addressing genetic disorders by selectively inhibiting the expression of harmful or disease-causing genes. For example, according to Down Syndrome UK, a charity based in the UK, Down syndrome affects around 40,000 people in the UK, with approximately 1 in every 800 babies being born with the condition. This growing prevalence of genetic disorders is fueling the gene silencing market.
Leading companies in the gene silencing market are focusing on the development of innovative technologies, such as small interfering RNA (siRNA), to improve the precision and efficacy of gene therapy. Small interfering RNA (siRNA) is an RNA molecule that plays a key role in the RNA interference (RNAi) pathway by binding to specific messenger RNA (mRNA) and promoting its degradation, thereby preventing the production of disease-causing proteins. For instance, in October 2024, Judo Bio Inc., a biotechnology company based in the US, launched a next-generation siRNA drug designed to silence genes. The drug incorporates proprietary delivery systems, such as lipid nanoparticles or conjugated ligands, which ensure efficient uptake by specific cells or tissues, along with AI-driven platforms that accelerate the identification of potential gene targets.
In September 2023, Regeneron Pharmaceuticals Inc., a US-based biotechnology company, acquired Decibel Therapeutics for an undisclosed amount. This acquisition aims to strengthen Regeneron's genetic medicine and gene therapy capabilities, with a particular focus on developing treatments for sensory disorders, such as genetic hearing loss. Decibel Therapeutics, a US-based company, specializes in gene therapies for hearing loss, including its lead program, DB-OTO, which utilizes a gene silencing approach.
Major players in the gene silencing market are Roche Holding AG, Merck & Co. Inc., AstraZeneca plc, Novartis International AG, Thermo Fisher Scientific Inc., Danaher Corporation, Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., Bio-Techne Corporation, Alnylam Pharmaceuticals Inc., GenScript Biotech Corporation, Oxford BioMedica plc, Ionis Pharmaceuticals Inc., Arrowhead Pharmaceuticals Inc., Dicerna Pharmaceuticals Inc., New England Biolabs Inc., Quark Pharmaceuticals Inc., Sirion Biotech GmbH, Benitec Biopharma Limited, GeneCopoeia Inc., Revvity Inc.
North America was the largest region in the gene silencing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in gene silencing report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the gene silencing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The gene silencing market consists of revenues earned by entities by providing services such as services such as gene knockdown assays, RNAi screening services, and epigenetic gene silencing services. The market value includes the value of related goods sold by the service provider or included within the service offering. The cholestatic pruritus market also includes sales of small interfering RNA, miRNA mimics and inhibitors, reporter assay kits, and therapeutic RNAi-based drugs. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Gene Silencing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on gene silencing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for gene silencing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The gene silencing market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Type: Transcriptional; Post-Transcriptional; Meiotic
2) By Gene Silencing: RNA Interference (RNAi); Antisense Oligonucleotides (ASOs); Clustered Regularly Interspaced Short Palindromic Repeats(CRISPR) Or Cas9 -Based Gene Silencing; Other Gene Silencings
3) By Application: Neurology; Oncology; Infectious Diseases; Metabolic Diseases; Therapeutics Manufacturing; Other Applications
4) By End-Users: Pharmaceutical And Biotechnology Companies; Research Institutes and Academic Centers; Hospitals; Clinics; Other End-Users
Subsegments:
1) By Transcriptional: DNA Methylation; Histone Modification
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Gene Silencing Market Characteristics
3. Gene Silencing Market Trends And Strategies
4. Gene Silencing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Gene Silencing Growth Analysis And Strategic Analysis Framework
5.1. Global Gene Silencing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Gene Silencing Market Growth Rate Analysis
5.4. Global Gene Silencing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Gene Silencing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Gene Silencing Total Addressable Market (TAM)
6. Gene Silencing Market Segmentation
6.1. Global Gene Silencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Transcriptional
Post-Transcriptional
Meiotic
6.2. Global Gene Silencing Market, Segmentation By Gene Silencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
RNA Interference (RNAi)
Antisense Oligonucleotides (ASOs)
Clustered Regularly Interspaced Short Palindromic Repeats(CRISPR) Or Cas9 -Based Gene Silencing
Other Gene Silencings
6.3. Global Gene Silencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Neurology
Oncology
Infectious Diseases
Metabolic Diseases
Therapeutics Manufacturing
Other Applications
6.4. Global Gene Silencing Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pharmaceutical And Biotechnology Companies
Research Institutes and Academic Centers
Hospitals
Clinics
Other End-Users
6.5. Global Gene Silencing Market, Sub-Segmentation Of Transcriptional, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
DNA Methylation
Histone Modification
6.6. Global Gene Silencing Market, Sub-Segmentation Of Post-Transcriptional, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
RNA Interference (RNAi)
Antisense Oligonucleotides
MicroRNA (miRNA) Mediated Silencing
6.7. Global Gene Silencing Market, Sub-Segmentation Of Meiotic, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Meiotic Gene Conversion
Transposable Element Silencing
7. Gene Silencing Market Regional And Country Analysis
7.1. Global Gene Silencing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Gene Silencing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Gene Silencing Market
8.1. Asia-Pacific Gene Silencing Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Gene Silencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Gene Silencing Market, Segmentation By Gene Silencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Gene Silencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Gene Silencing Market
9.1. China Gene Silencing Market Overview
9.2. China Gene Silencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Gene Silencing Market, Segmentation By Gene Silencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Gene Silencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Gene Silencing Market
10.1. India Gene Silencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Gene Silencing Market, Segmentation By Gene Silencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Gene Silencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Gene Silencing Market
11.1. Japan Gene Silencing Market Overview
11.2. Japan Gene Silencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Gene Silencing Market, Segmentation By Gene Silencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Gene Silencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Gene Silencing Market
12.1. Australia Gene Silencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Gene Silencing Market, Segmentation By Gene Silencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Gene Silencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Gene Silencing Market
13.1. Indonesia Gene Silencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Gene Silencing Market, Segmentation By Gene Silencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Gene Silencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Gene Silencing Market
14.1. South Korea Gene Silencing Market Overview
14.2. South Korea Gene Silencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Gene Silencing Market, Segmentation By Gene Silencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Gene Silencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Gene Silencing Market
15.1. Western Europe Gene Silencing Market Overview
15.2. Western Europe Gene Silencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Gene Silencing Market, Segmentation By Gene Silencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Gene Silencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Gene Silencing Market
16.1. UK Gene Silencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Gene Silencing Market, Segmentation By Gene Silencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Gene Silencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Gene Silencing Market
17.1. Germany Gene Silencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Gene Silencing Market, Segmentation By Gene Silencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Gene Silencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Gene Silencing Market
18.1. France Gene Silencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Gene Silencing Market, Segmentation By Gene Silencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Gene Silencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Gene Silencing Market
19.1. Italy Gene Silencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Gene Silencing Market, Segmentation By Gene Silencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Gene Silencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Gene Silencing Market
20.1. Spain Gene Silencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Gene Silencing Market, Segmentation By Gene Silencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Gene Silencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Gene Silencing Market
21.1. Eastern Europe Gene Silencing Market Overview
21.2. Eastern Europe Gene Silencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Gene Silencing Market, Segmentation By Gene Silencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Gene Silencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Gene Silencing Market
22.1. Russia Gene Silencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Gene Silencing Market, Segmentation By Gene Silencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Gene Silencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Gene Silencing Market
23.1. North America Gene Silencing Market Overview
23.2. North America Gene Silencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Gene Silencing Market, Segmentation By Gene Silencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Gene Silencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Gene Silencing Market
24.1. USA Gene Silencing Market Overview
24.2. USA Gene Silencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Gene Silencing Market, Segmentation By Gene Silencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Gene Silencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Gene Silencing Market
25.1. Canada Gene Silencing Market Overview
25.2. Canada Gene Silencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Gene Silencing Market, Segmentation By Gene Silencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Gene Silencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Gene Silencing Market
26.1. South America Gene Silencing Market Overview
26.2. South America Gene Silencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Gene Silencing Market, Segmentation By Gene Silencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Gene Silencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Gene Silencing Market
27.1. Brazil Gene Silencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Gene Silencing Market, Segmentation By Gene Silencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Gene Silencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Gene Silencing Market
28.1. Middle East Gene Silencing Market Overview
28.2. Middle East Gene Silencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Gene Silencing Market, Segmentation By Gene Silencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Gene Silencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Gene Silencing Market
29.1. Africa Gene Silencing Market Overview
29.2. Africa Gene Silencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Gene Silencing Market, Segmentation By Gene Silencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Gene Silencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Gene Silencing Market Competitive Landscape And Company Profiles
30.1. Gene Silencing Market Competitive Landscape
30.2. Gene Silencing Market Company Profiles
30.2.1. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.3. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Novartis International AG Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
31. Gene Silencing Market Other Major And Innovative Companies
31.1. Danaher Corporation
31.2. Agilent Technologies Inc.
31.3. Illumina Inc.
31.4. Bio-Rad Laboratories Inc.
31.5. Bio-Techne Corporation
31.6. Alnylam Pharmaceuticals Inc.
31.7. GenScript Biotech Corporation
31.8. Oxford BioMedica plc
31.9. Ionis Pharmaceuticals Inc.
31.10. Arrowhead Pharmaceuticals Inc.
31.11. Dicerna Pharmaceuticals Inc.
31.12. New England Biolabs Inc.
31.13. Quark Pharmaceuticals Inc.
31.14. Sirion Biotech GmbH
31.15. Benitec Biopharma Limited
32. Global Gene Silencing Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Gene Silencing Market
34. Recent Developments In The Gene Silencing Market
35. Gene Silencing Market High Potential Countries, Segments and Strategies
35.1 Gene Silencing Market In 2029 - Countries Offering Most New Opportunities
35.2 Gene Silencing Market In 2029 - Segments Offering Most New Opportunities
35.3 Gene Silencing Market In 2029 - Growth Strategies
